This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Natalie has worked with private hospitals and clinics in relation to medical malpractice claims, and assisted on cases involving medical devices product liability and clinicaltrials. Our seminar on Wednesday 6 March will look at the use of medicinal cannabis in more detail.
Dr. Griffiths and Dr. Johnson will be speaking at Analgesic, Anesthetic, and Addiction ClinicalTrial Translations, Innovations, Opportunities, and Networks conference in Washington DC. Dr. Johnson will be presenting “Psychedelics and behavior change” at the Harvard/McLean Hospital’s Neuroscience Seminar Series.
upcoming seminars). It is unclear whether doctors are feeling completely reassured by laboratory and clinicaltrial research into medicinal cannabis. 14) and general information or guidelines for practitioners ( n ?=?6). Three articles were audience polls about medicinal cannabis and three were sponsored content (e.g.
That changed when I started looking into Hemp CBD pet products in preparing for a CLE put on by the Seminar Group. When it comes to CBD the, research is limited but a small clinicaltrial at Colorado State University found that CBD oil reduced seizures in epileptic dogs meaning that it may have similar effects as found in humans.
fast-tracked clinicaltrials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex. There haven’t been enough clinicaltrials and there never will be,” said Mr. Clarke, the cannabis seed collector. And with this group, finally, it seemed to be coming together. The Stanleys told me their wait-list peaked at 15,000 names.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content